Table 1.

Arv Drug Combinations Only Available as Generics

AZT/3TC/NVP: Adult formulations by Aspen, Apotex, Aurobindo, Cipla, Hetero, Matrix, Emcure, Ranbaxy, and Strides. The Clinton Foundation has negotiated reduced prices with Cipla and Matrix. Paediatric formulations by Government Pharmaceutical Organization (GPO) and Ranbaxy.

D4T/3TC/NVP: The Clinton Foundation has negotiated with Hetero, Matrix, Cipla and Ranbaxy reduced prices for adult formulations. Adult formulation also made by Emcure and Strides. Paediatric formulations by Cipla, GPO, Emcure, and Ranbaxy.

D4T/3TC: Adult formulations by Aurobindo, Cipla, Hetero, Matrix, Ranbaxy, Emcure, and Strides. Paediatric formulations by Emcure and Ranbaxy.

D4T/3TC+EFV: Adult formulations by Cipla, Emcure, Strides and Ranbaxy. No paediatric formulations.

AZT/3TC+EFV: Adult formulations by Aurobindo, Cipla, Emcure, Ranbaxy, and Strides. No paediatric formulations.

PMTCT:NVP+AZT:Granule formulations by Strides.

TDF/3TC:Adult formulation by Matrix (reduced price in the Clinton Foundation’s consortium). Not for paediatric use.

TDF/3TC+EFV:Adult formulation by Cipla. Not for paediatric use.

TDF/3TC/EFV:Adult formulation by Matrix (reduced price in the Clinton Foundation’s consortium). Not for paediatric use.

AZT=zidovudine, 3TC=lamivudine, NVP=nevirapine, D4T=stavudine, EFV=efavirenz, TDF=tenofovir, PMTCT=prevention mother-to-child transmission.

WHO prequalified ARVs (updated list) at http://healthtech.who.int/pq/status/Product Registry.aspx?list=ha